Clinical Trial Update: Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix [Phase 2]

View source ↗

Summary

Phase II trial evaluating a combination of cisplatin, topotecan, and cetuximab in patients with late-stage or progressing cervical cancer; the study (NCT0051819…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Topotecan (topotecan)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Cervix Cancer | Phase 2 | Status: TERMINATED